Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Avant Technologies ( (AVAI) ) is now available.
On September 15, 2025, Avant Technologies Inc. entered into a Joint Venture and License Agreement with SGAustria Pte. Ltd., forming a new company, Klothonova Inc. This partnership aims to leverage Austrianova’s expertise in cell biology and proprietary cell encapsulation technology, with Avant Technologies providing up to $1.5 million USD in capital and resources for the next 18 months. Both companies will hold equal ownership in Klothonova, which will be governed by a limited liability company agreement. This collaboration is expected to enhance Avant Technologies’ position in the biotech industry by combining resources and expertise with Austrianova.
More about Avant Technologies
Avant Technologies Inc. operates in the technology sector, focusing on innovative solutions and partnerships to enhance its market presence. The company is involved in forming strategic alliances to expand its capabilities and offerings.
Average Trading Volume: 118,404
Technical Sentiment Signal: Strong Sell
Current Market Cap: $48.87M
For detailed information about AVAI stock, go to TipRanks’ Stock Analysis page.